natgillin/translations-raw huggingface dataset:
An improvement in pruritus of more than 50 % was observed in 55 % of patients treated with desloratadine compared with 19 % of patients treated with placebo. 
Zabilježeno je smanjenje svrbeža za više od 50 % kod 55 % bolesnika liječenih desloratadinom, u usporedbi s 19 % bolesnika koji su primali placebo.
There is no evidence of clinically relevant medicine accumulation following once daily dosing of desloratadine (5 mg to 20 mg) for 14 days. 
Ne postoji dokaz o klinički značajnoj akumulaciji lijeka nakon primjene desloratadina jednom dnevno (5 mg do 20 mg) tijekom 14 dana.
Desloratadine ratiopharm 5 mg film-coated tablets are supplied in PVC/PVdC/aluminium blister packs of 7, 10, 14, 15, 20, 30, 40, 50, 60, 90 and 100 film-coated tablets. 
Desloratadin ratiopharm 5 mg filmom obložene tablete dostupne su u PVC/PVdC/aluminij blister pakiranjima od 7, 10, 14, 15, 20, 30, 40, 50, 60, 90 i 100 filmom obloženih tableta.
However, fatigue, dry mouth and headache were reported more often than with a dummy tablet. 
Međutim, češće su zabilježeni umor, suha usta i glavobolja nego kod primjene tablete placeba.
Hypersensitivity to the active substance, to any of the excipients listed in section 6.1 or to loratadine. 
Preosjetljivost na djelatnu tvar, neku od pomoćnih tvari navedenih u dijelu 6.1 ili loratadin.
In clinical studies with desloratadine, the following side effects were reported as: 
U kliničkim ispitivanjima s desloratadinom, sljedeće nuspojave bile su prijavljene kao:
In a clinical trial with 578 adolescent patients, 12 through 17 years of age, the most common adverse event was headache; this occurred in 5.9 % of patients treated with desloratadine and 6.9 % of patients receiving placebo. 
U kliničkom ispitivanju s 578 ispitanika adolescenata, u dobi od 12 do 17 godina, najčešći štetni događaj bila je glavobolja koja se javljala u 5,9 % bolesnika liječenih desloratadinom i u 6,9 % bolesnika koji su primali placebo.
These include inhibiting the release of proinflammatory cytokines such as IL-4, IL-6, IL-8, and IL-13 from human mast cells/basophils, as well as inhibition of the expression of the adhesion molecule P-selectin on endothelial cells. 
Ova svojstva uključuju ihibiciju otpuštanja proinflamatornih citokina poput IL-4, IL-6, IL-8 i IL-13 iz ljudskih mastocita/bazofila, kao i inhibiciju ekspresije adhezijske molekule P-selektina na endotelnim stanicama.
Adverse reactions seen with desloratadine 
Nuspojave opažene uz desloratadin
The safety and efficacy of Desloratadine ratiopharm 5 mg film-coated tablets in children below the age of 12 years have not been established. 
Sigurnost i djelotvornost Desloratadin ratiopharm 5 mg filmom obloženih tableta u djece mlađe od 12 godina nisu ustanovljene.
Very rare: the following may affect up to 1 in 10,000 people ● severe allergic reactions 
Vrlo rijetke (javljaju se u manje od 1 na 10 000 osoba): ● teške alergijske reakcije ● osip
Film-coating: 
Film ovojnica:
A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from Desloratadine ratiopharm 5 mg film-coated tablets therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman. 
Potrebno je odlučiti da li prekinuti dojenje ili prekinuti liječenje/suzdržati se od liječenja Desloratadin ratiopharm 5 mg filmom obloženim tabletama uzimajući u obzir korist dojenja za dijete i korist liječenja za ženu.
METHOD AND ROUTE(S) OF ADMINISTRATION Swallow the tablet whole with water. 
NAČIN I PUT(EVI) PRIMJENE LIJEKA Tabletu progutajte cijelu s vodom.
At the recommended dose, this medicine is not expected to affect your ability to drive or use machines. 
Ako se uzme u preporučenoj dozi, ovaj lijek ne bi trebao utjecati na Vašu sposobnost upravljanja vozilima i rada sa strojevima.
In two placebo-controlled six week trials in patients with chronic idiopathic urticaria, desloratadine was effective in relieving pruritus and decreasing the size and number of hives by the end of the first dosing interval. 
U dva placebo-kontrolirana klinička ispitivanja u trajanju od šest tjedana kod bolesnika s kroničnom idiopatskom urtikarijom, desloratadin je učinkovito ublažavao svrbež i smanjivao veličinu i broj koprivnjača do kraja prvog intervala doziranja.
Desloratadine was effective in alleviating the burden of seasonal allergic rhinitis as shown by the total score of the rhino-conjunctivitis quality of life questionnaire. 
Desloratadin je bio učinkovit u ublažavanju simptoma sezonskog alergijskog rinitisa, što se vidi iz ukupnog rezultata upitnika o kvaliteti života ispitanika s rinokonjuktivitisom.
What Desloratadine ratiopharm looks like and contents of the pack Round, biconvex, blue film-coated tablets. 
Kako Desloratadin ratiopharm izgleda i sadržaj pakiranja Okrugle, bikonveksne, plave filmom obložene tablete
In adolescents, headache was the most commonly reported side effect. 
U adolescenata, najčešće zabilježena nuspojava bila je glavobolja.
The degree of accumulation of desloratadine was consistent with its half-life (approximately 27 hours) and a once daily dosing frequency. 
Stupanj nakupljanja desloratadina bio je u skladu s njegovim poluvijekom (približno 27 sati) i s učestalosti doziranja jednom dnevno.
Teva Operations Poland Sp. Z o.o. 
Teva Operations Poland Sp. Z o.o. ul.
Round, biconvex, blue film-coated tablets. 
Okrugle, bikonveksne, plave filmom obložene tablete
Pharmacotherapeutic group: antihistamines - H1 antagonist, ATC code: R06A X27 
Farmakoterapijska skupina: Ostali antihistaminici za sustavnu primjenu, ATK oznaka: R06AX27
Use caution when taking Desloratadine ratiopharm with alcohol. 
Potreban je oprez kada se Desloratadin ratiopharm uzima s alkoholom.
In a pharmacokinetic trial in which patient demographics were comparable to those of the general seasonal allergic rhinitis population, 4 % of the subjects achieved a higher concentration of desloratadine. 
U farmakokinetičkom ispitivanju u kojem su demografski podaci ispitanika bili usporedivi s podacima opće populacije koja je imala sezonski alergijski rinitis, 4 % ispitanika imalo je višu koncentraciju desloratadina.
Desloratadine is a non-sedating, long-acting histamine antagonist with selective peripheral H1-receptor antagonist activity. 
Desloratadin je dugodjelujući antagonist histamina bez sedativnog učinka, sa selektivnim antagonističkim djelovanjem na periferne H1-receptore.
Maximum desloratadine concentration was about 3-fold higher at approximately 7 hours with a terminal phase half-life of approximately 89 hours. 
Maksimalna koncentracija desloratadina bila je oko 3 puta veća od uobičajene nakon približno 7 sati od primjene, s poluvijekom u terminalnoj fazi od oko 89 sati.
Desloratadine ratiopharm 5 mg film-coated tablets is indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1) 
Desloratadin ratiopharm 5 mg filmom obložene tablete indicirane su u odraslih i adolescenata u dobi od 12 ili više godina za ublažavanje simptoma povezanih s: - alergijskim rinitisom (vidjeti dio 5.1), - urtikarijom (vidjeti dio 5.1).
During the marketing of Desloratadine ratiopharm, cases of severe allergic reactions (difficulty in breathing, wheezing, itching, hives and swelling) have been reported very rarely. 
Nakon stavljanja u promet lijeka Desloratadin ratiopharm, slučajevi teških alergijskih reakcija (otežano disanje, zviždanje pri disanju, svrbež, koprivnjača i oticanje) bili su prijavljeni vrlo rijetko.
QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 5 mg desloratadine. 
KVALITATIVNI I KVANTITATIVNI SASTAV Jedna tableta sadrži 5 mg desloratadina.
How to store Desloratadine ratiopharm Contents of the pack and other information 
Kako čuvati Desloratadin ratiopharm Sadržaj pakiranja i druge informacije
In controlled clinical trials, at the recommended dose of 5 mg daily, there was no excess incidence of somnolence as compared to placebo. 
U kontroliranim kliničkim ispitivanjima, kod preporučene doze od 5 mg dnevno, nije bila povećana incidencija somnolencije u usporedbi s placebom.
Desloratadine given at a single daily dose of 7.5 mg did not affect psychomotor performance in clinical trials. 
Desloratadin primijenjen u jednokratnoj dnevnoj dozi od 7,5 mg nije imao učinak na psihomotorne sposobnosti u kliničkim ispitivanjima.
España ratiopharm España, S.A. Tel: +34 91 567 29 70 
Polska ratiopharm España, S.A. Tel: +34 91 567 29 70
What Desloratadine ratiopharm is and what it is used for 
Što je Desloratadin ratiopharm i za što se koristi
In a multiple dose clinical trial, in which up to 20 mg of desloratadine was administered daily for 14 days, no statistically or clinically relevant cardiovascular effect was observed. 
U kliničkom ispitivanju višestrukih doza, u kojem se primjenjivalo do 20 mg desloratadina dnevno tijekom 14 dana, nije uočen klinički ili statistički značajan kardiovaskularni učinak.
Film-coating: polyvinyl alcohol (part. hydrolysed), titanium dioxide (E171), macrogol/PEG 3350, talc and indigo carmine aluminium lake (E132). 
- Film ovojnica: poli(vinilni alkohol) (djelomično hidroliziran), titanijev dioksid (E171),makrogol/PEG3350, talk i indigo carmine aluminium lake (E132).
In clinical trials in a range of indications including allergic rhinitis and chronic idiopathic urticaria, at the recommended dose of 5 mg daily, undesirable effects with desloratadine were reported in 3 % of patients in excess of those treated with placebo. 
U kliničkim ispitivanjima kod različitih indikacija, uključujući alergijski rinitis i kroničnu idiopatsku urtikariju, pri preporučenoj dozi od 5 mg dnevno, kod primjene desloratadina zabilježene su nuspojave u 3 % više bolesnika nego u onih koji su primali placebo.
In the case of severe renal insufficiency, Desloratadine ratiopharm 5 mg film-coated tablets should be used with caution (see section 5.2). 
U slučaju teške insuficijencije bubrega, Desloratadin ratiopharm 5 mg filmom obložene tablete treba oprezno primjenjivati (vidjeti dio 5.2).
Adults During the marketing of Desloratadine ratiopharm, the following side effects were reported as: 
Odrasli Nakon stavljanja u promet lijeka Desloratadin ratiopharm, sljedeće su nuspojave prijavljene kao:
Intermittent allergic rhinitis is defined as the presence of symptoms for less than 4 days per week or for less than 4 weeks. 
Intermitentni alergijski rinitis definira se kao prisutnost simptoma alergijskog rinitisa manje od 4 dana u tjednu ili kraće od 4 tjedna.
305 74770 Opava-Komárov Czech Republic 
Ostravaská 29, c.p. 305 74770 Opava-Komárov Češka
Desloratadine ratiopharm is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy). 
Desloratadin ratiopharm se također koristi za ublažavanje simptoma povezanih s urtikarijom (promjene na koži uslijed alergije).
If your allergic rhinitis is intermittent (presence of symptoms for less than 4 days per week or for less than 4 weeks), your doctor will recommend you a treatment schedule that will depend on the evaluation of the history of your disease. 
Ako je Vaš alergijski rinitis povremen (simptomi su prisutni manje od 4 dana u tjednu ili manje od 4 tjedna), liječnik će Vam preporučiti raspored liječenja koji će ovisiti o procjeni Vaše povijesti bolesti.
Other undesirable effects reported during the post-marketing period in paediatric patients with an unknown frequency included QT prolongation, arrhythmia, bradycardia, abnormal behaviour, and aggression. 
Ostale nuspojave nepoznate učestalosti prijavljene u pedijatrijskih bolesnika nakon stavljanja lijeka u promet uključivale su produljenje QT intervala, aritmiju, bradikardiju, neuobičajeno ponašanje i agresiju.
Pharmachemie B.V. Swensweg 5, 2031 GA Haarlem The Netherlands 
Swensweg 5, 2031 GA Haarlem Nizozemska
When Desloratadine ratiopharm should be used Desloratadine ratiopharm relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults and adolescents 12 years of age and older. 
Desloratadin ratiopharm ublažava simptome povezane s alergijskim rinitisom (upala nosnih puteva uzrokovana alergijom, na primjer, kod peludne groznice ili alergije na grinje) u odraslih osoba i adolescenata u dobi od 12 ili više godina.
In a clinical pharmacology trial desloratadine tablets taken concomitantly with alcohol did not potentiate the performance impairing effects of alcohol (see section 5.1). 
U kliničkom farmakološkom ispitivanju, uzimanje desloratadin tableta s alkoholom nije pojačalo štetne učinke alkohola na ponašanje (vidjeti dio 5.1).
As a precautionary measure, it is preferable to avoid the use of Desloratadine ratiopharm 5 mg film-coated tablets during pregnancy. 
Kao mjera opreza, preporučuje se izbjegavati primjenu Desloratadin ratiopharm 5 mg filmom obloženih tableta tijekom trudnoće.
No clinically relevant interactions were observed in clinical trials with desloratadine tablets in which erythromycin or ketoconazole were co-administered (see section 5.1). 
Klinički značajne interakcije nisu opažene u kliničkim ispitivanjima istodobne primjene tableta desloratadina s eritromicinom ili ketokonazolom (vidjeti dio 5.1).
Desloratadine ratiopharm is an antiallergy medicine that does not make you drowsy. 
Desloratadin ratiopharm je lijek protiv alergije koji ne izaziva pospanost.
Elevations of liver enzymes, increased bilirubin, hepatitis Jaundice 
Poremećaji jetre i žuči vrlo rijetko nepoznato povećanje jetrenih enzima, povišeni bilirubin, hepatitis žutica
The recommended dose of Desloratadine ratiopharm 5 mg film-coated tablets is one tablet once a day. 
Preporučena doza Desloratadin ratiopham 5 mg filmom obloženih tableta je jedna tableta jedanput na dan.
What Desloratadine ratiopharm is and what it is used for What you need to know before you take Desloratadine ratiopharm How to take Desloratadine ratiopharm Possible side effects 
Što je Desloratadin ratiopharm i za što se koristi Što morate znati prije nego počnete uzimati Desloratadin ratiopharm
In patients with allergic rhinitis, desloratadine was effective in relieving symptoms such as sneezing, nasal discharge and itching, as well as ocular itching, tearing and redness, and itching of palate. 
Kod bolesnika s alergijskim rinitisom, desloratadin je bio učinkovit u ublažavanju simptoma kao što su kihanje, curenje i svrbež nosa, kao i svrbež, suzenje i crvenilo očiju te svrbež nepca.
Desloratadine ratiopharm tablets contains lactose. 
Desloratadin ratiopharm tablete sadrže laktozu.
In a single dose study performed in adults, desloratadine 5 mg did not affect standard measures of flight performance including exacerbation of subjective sleepiness or tasks related to flying. 
U ispitivanju učinka jednokratnih doza desloratadina od 5 mg kod odraslih osoba, nije bilo utjecaja na standardna mjerila uspješnosti upravljanja letjelicama, uključujući i egzacerbaciju subjektivnog osjećaja pospanosti ili zadataka vezanih uz upravljanje letjelicama.
In a clinical pharmacology trial, in which desloratadine was administered at a dose of 45 mg daily (nine times the clinical dose) for ten days, no prolongation of QTc interval was seen. 
U kliničkom farmakološkom ispitivanju u kojem se desloratadin primjenjivao u dozi od 45 mg dnevno (devet puta većoj dozi od kliničke) tijekom deset dana, nije opaženo produljenje QTc intervala.
Tablet core: poloxamer type 188, citric acid monohydrate, microcrystalline cellulose, maize starch, croscarmellose sodium, lactose monohydrate (see section 2 “Desloratadine ratiopharm contains lactose”), talc, 
- Drugi sastojci su: Jezgra tablete: poloksamer vrste 188, citratna kiselina hidrat, mikrokristalična celuloza, kukuruzni škrob, umrežena karmelozanatrij, laktoza hidrat (pogledajte dio 2 „Desloratadin ratiopharm sadrži laktozu“), talk.
● weight increased 
● povećana tjelesna težina
INFORMATION IN BRAILLE Desloratadine ratiopharm 5 mg 17. 
16. PODACI NA BRAILLEOVOM PISMU Desloratadin ratiopharm 5 mg
What Desloratadine ratiopharm is Desloratadine ratiopharm contains desloratadine which is an antihistamine. 
Što je Desloratadin ratiopharm Desloratadin ratiopharm sadrži desloratadin, koji je antihistaminik.
Polyvinyl alcohol (part. hydrolysed) Titanium dioxide (E171) Macrogol/PEG 3350 
poli(vinilni alkohol) (djelomično hidroliziran) titanijev dioksid (E171) makrogol/PEG 3350 talk indigo carmine aluminium lake (E132)
Polska 
Poljska
What you need to know before you take Desloratadine ratiopharm Do not take Desloratadine ratiopharm - if you are allergic to desloratadine or any of the other ingredients of this medicine (listed in section 6) or to loratadine. 
• ako ste alergični na desloratadin ili neki drugi sastojak ovog lijeka (naveden u dijelu 6) ili na loratadin.
Other medicines and Desloratadine ratiopharm There are no known interactions of Desloratadine ratiopharm with other medicines. 
Nema poznatih interakcija između lijeka Desloratadin ratiopharm i drugih lijekova.
Dizziness, somnolence, insomnia, psychomotor hyperactivity, seizures 
Poremećaji živčanog sustava često vrlo rijetko glavobolja omaglica, somnolencija, nesanica, psihomotorna hiperaktivnost, napadaji
Tel: +39 02 8917981 
Teva Italia s.r.l. Tel: +39 02 8917981
Desloratadine ratiopharm 5 mg film-coated tablets desloratadine 
Desloratadin ratiopharm 5 mg filmom obložene tablete desloratadin
Poloxamer type 188 Citric acid monohydrate Microcrystalline cellulose Maize starch 
poloksamer vrste 188 citratna kiselina hidrat celuloza, mikrokristalična (E460) kukuruzni škrob karmelozanatrij, umrežena laktoza hidrat talk
Desloratadine ratiopharm contains lactose 
Desloratadin ratiopharm sadrži laktozu
If your allergic rhinitis is persistent (presence of symptoms for 4 days or more per week and for more than 4 weeks), your doctor may recommend you a longer term treatment. 
Ako bolujete od dugotrajnog alergijskog rinitisa (simptomi su prisutni 4 ili više dana u tjednu i duže od 4 tjedna) liječnik Vam može propisati dugotrajnije liječenje.
Metabolism and nutrition disorders 
Poremećaji metabolizma i prehrane nepoznata povećan apetit
If you take more Desloratadine ratiopharm than you should 
Ako uzmete više Desloratidana ratiopharm nego što ste trebali Uzimajte Desloratadin ratiopharm samo na način kako Vam je propisano.
NAME OF THE MEDICINAL PRODUCT Desloratadine ratiopharm 5 mg film-coated tablets 
NAZIV LIJEKA Desloratadin ratiopharm 5 mg filmom obložene tablete
305, 74770 Opava-Komarov Czech Republic 
Teva Czech Industries s.r.o Ostravska 29, c.p. 305, 74770 Opava-Komarov Češka
What Desloratadine ratiopharm contains - The active substance is desloratadine 5 mg. - The other ingredients are: 
Što Desloratadin ratiopharm sadrži - Djelatna tvar je desloratadin 5 mg.
● liver inflammation ● abnormal liver function tests body movement 
● odstupanja od normalnih rezultata pokretima tijela
STATEMENT OF ACTIVE SUBSTANCE(S) Each film-coated tablet contains 5 mg desloratadine. 
TVARI Jedna filmom obložena tableta sadrži 5 mg desloratadina.
How to take Desloratadine ratiopharm 
Kako uzimati Desloratadin ratiopharm
How to store Desloratadine ratiopharm 
Kako čuvati Desloratadin ratiopharm
Marketing Authorisation Holder ratiopharm GmbH Graf-Arco-Straße 3 
Nositelj odobrenja za stavljanje gotovog lijeka u promet ratiopharm GmbH
BATCH NUMBER 
IME NOSITELJA
Hypersensitivity reactions (such as anaphylaxis, angioedema, dyspnoea, pruritus, rash and urticaria) Asthenia 
Opći poremećaji i reakcije na mjestu primjene često vrlo rijetko nepoznato umor reakcije preosjetljivosti (poput anafilaksije, angioedema, dispneje, pruritusa, osipa i urtikarije) astenija
Gastrointestinal disorders 
● testova jetrene funkcije
If you stop taking Desloratadine ratiopharm If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse. 
U slučaju bilo kakvih pitanja u vezi s primjenom ovog lijeka, obratite se svom liječniku, ljekarniku ili medicinskoj sestri.
Myalgia 
Dojenje
● dizziness 
● nesanica
However, if you take more Desloratadine ratiopharm than you were told to, tell your doctor, pharmacist or nurse immediately. 
Vam je propisano, odmah o tome obavijestite svog liječnika, ljekarnika ili medicinsku sestru.
How Desloratadine ratiopharm works 
Kako djeluje Desloratadin ratiopharm
3 years. 
3 godina.
Most of them occurred during the first months of treatment. 
Većina ih je nastala tijekom prvih mjeseci liječenja.
NN: {number}, if applicable nationally 
NN: {broj}, ako je primjenjivo na nacionalnoj razini
In such cases doubling of the daily dose may be necessary. 
U takvim slučajevima može biti potrebno udvostručiti dnevnu dozu.
Very rare (< 1/10,000), not known (cannot be estimated from the available data). 
Vrlo rijetko (< 1/10 000), nepoznato (ne može se procijeniti iz dostupnih podataka).
See section 2 Warnings and precautions. 
Pogledajte dio 2 Upozorenja i mjere opreza.
EFFECTIVE USE OF THE MEDICINAL PRODUCT · Risk Management Plan (RMP) 
LIJEKA · Plan upravljanja rizikom (RMP)
Afterwards gynaecological examination should be repeated at least once a year. 
Naknadni ginekološki pregled se mora ponoviti najmanje jednom godišnje.
Read all of this leaflet carefully before you start using this medicine because it contains important information for you. 
Pažljivo pročitajte cijelu uputu prije nego počnete uzimati ovaj lijek, jer sadrži Vama važne podatke.
There is no specific antidote and the treatment is symptomatic. 
Ne postoji specifičan antidot, a liječenje je simptomatsko.
Date of latest renewal: 2 February 2006 
Datum posljednje obnove odobrenja: 2. veljače 2006.
No information is available concerning polymorphic metabolism. 
Nisu dostupne informacije u vezi polimorfnog metabolizma.
Contact your doctor, pharmacist or the nearest hospital immediately. 
Odmah obavijestite svog liječnika, ljekarnika ili najbližu bolnicu.
The other findings are not toxicologically significant. 
Drugi nalazi nisu toksikološki značajni.
The changes due to food intake are not clinically significant. 
Promjene uzrokovane unosom hrane nisu klinički značajne.
What Fareston is and what it is used for 
Što je Fareston i za što se koristi
The half-life of the first (distribution) phase is 4 (range 2 - 12) hours, and of the second (elimination) phase 5 (range 210) days. 
Poluvijek prve faze (distribucija) je četiri (2 - 12 sati) sata, a druge faze (eliminacija) 5 (2 - 10 dana) dana.
Warnings and precautions Talk to your doctor or pharmacist before taking Fareston: 
Upozorenja i mjere opreza Obratite se svom liječniku ili ljekarniku prije nego uzmete Fareston:
Food intake has no effect on the extent of absorption but may delay the peak concentrations by 1.5 - 2 hours. 
Unos hrane nema utjecaja na stupanj apsorpcije, ali može odgoditi pojavu vršnih koncentracija za 1,5 - 2 sata.
The dose of some of these may have to be adjusted while you are on Fareston. 
Doza nekih od ovih lijekova možda će se morati prilagođavati dok se liječite Farestonom.
These results strongly suggest an important dose-dependent effect. 
Ti rezultati snažno ukazuju na važan učinak ovisan o dozi.
If the QTc interval is > 500 ms, Fareston should not be used. 
Ako je QTc interval > 500 ms, Fareston se ne smije primjenjivati.
If you miss one dose take the next tablet as usual and continue treatment as recommended. 
Ako propustite jednu dozu, uzmite sljedeću tabletu prema uobičajenom rasporedu i nastavite liječenje prema preporuci.
Clinical anti-tumour efficacy and serum concentrations have no positive correlation at the recommended daily dose of 60 mg. 
Klinička antitumorska djelotvornost i serumske koncentracije nemaju pozitivnu korelaciju pri preporučenoj dnevnoj dozi od 60 mg.
Enterohepatic circulation can be expected. 
Može se očekivati ulazak u enterohepatičku cirkulaciju.
If you are admitted to the hospital or if you are prescribed a new medicine, please tell your doctor that you are taking Fareston. 
Ako ste primljeni u bolnicu ili Vam je propisan novi lijek, molimo obavijestite svog liječnika da uzimate Fareston.
Pharmacotherapeutic group: Anti-estrogens, ATC code: L02BA02 
Farmakoterapijska skupina: anti-estrogeni, ATK oznaka: L02BA02